T1	Condition 692 711	inducible urticaria
T2	Condition-Name 692 711	inducible urticaria
E1	Condition:T1 Name:T2
T3	Condition 1031 1055	opportunistic infections
T4	Condition-Name 1031 1055	opportunistic infections
E3	Condition:T3 Name:T4
T7	Condition 665 682	chronic urticaria
T8	Condition-Name 665 682	chronic urticaria
E7	Condition:T7 Name:T8
T9	Condition 1083 1098	mycobacterioses
T10	Condition-Name 1083 1098	mycobacterioses
E9	Condition:T9 Name:T10
T11	Condition 1115 1128	aspergillosis
T12	Condition-Name 1115 1128	aspergillosis
E11	Condition:T11 Name:T12
T13	Procedure 1270 1283	contraception
T14	Procedure-Name 1270 1283	contraception
E13	Procedure:T13 Name:T14 Temporality:E82
T15	Condition 785 797	skin disease
T16	Condition-Name 785 797	skin disease
E15	Condition:T15 Name:T16
T17	Condition 1060 1072	tuberculosis
T18	Condition-Name 1060 1072	tuberculosis
E17	Condition:T17 Name:T18
T19	Condition 1100 1111	listeriosis
T20	Condition-Name 1100 1111	listeriosis
E19	Condition:T19 Name:T20
T21	Condition 1136 1145	Hepatitis
T22	Condition-Name 1136 1145	Hepatitis
E21	Condition:T21 Name:T22
T25	Condition 750 759	urticaria
T26	Condition-Name 750 759	urticaria
E25	Condition:T25 Name:T26
T27	Condition 1168 1175	nursing
T28	Condition-Name 1168 1175	nursing
E27	Condition:T27 Name:T28
T29	Life-Stage-And-Gender 34 40	female
A1	Life-Stage-And-Gender-Type T29 male
T30	Condition 151 156	hives
T31	Condition-Name 151 156	hives
E30	Condition:T30 Name:T31 Duration:E38
T32	Life-Stage-And-Gender 25 29	Male
A2	Life-Stage-And-Gender-Type T32 male
T33	Condition 77 80	CSU
T34	Condition-Name 77 80	CSU
E33	Condition:T33 Name:T34 Temporality:E37
T35	Eq-Operator 55 56	≥
A3	Eq-Operator-Value T35 GTEQ
T36	Eq-Operator 95 96	≥
A4	Eq-Operator-Value T36 GTEQ
T37	Eq-Operator 161 162	≥
A5	Eq-Operator-Value T37 GTEQ
T38	Eq-Operator 344 345	≥
A6	Eq-Operator-Value T38 GTEQ
T39	Eq-Operator 376 377	≥
A7	Eq-Operator-Value T39 GTEQ
T40	Eq-Temporal-Unit 59 64	years
A8	Eq-Temporal-Unit-Value T40 year
T41	Eq-Temporal-Unit 99 105	months
A9	Eq-Temporal-Unit-Value T41 month
T42	Eq-Temporal-Unit 176 181	weeks
A10	Eq-Temporal-Unit-Value T42 week
T43	Eq-Temporal-Unit 389 393	days
A11	Eq-Temporal-Unit-Value T43 day
T44	Age 50 54	aged
E34	Age:T44 Eq-Comparison:E36
T46	Eq-Operator 339 340	-
A12	Eq-Operator-Value T46 BETWEEN
T47	Eq-Operator 371 372	-
A13	Eq-Operator-Value T47 BETWEEN
T48	Eq-Value 56 58	18
T49	Eq-Value 97 98	6
T50	Eq-Value 162 163	6
T51	Eq-Value 338 339	0
T52	Eq-Value 340 342	42
T53	Eq-Value 345 347	16
T54	Eq-Value 370 371	0
T55	Eq-Value 372 374	21
T56	Eq-Value 378 379	8
T57	Eq-Value 387 388	7
T59	Eq-Comparison 55 64	≥18 years
E36	Eq-Comparison:T59 Operator:T35 Temporal-Unit:T40 Value:T48
T60	Eq-Comparison 95 105	≥ 6 months
E37	Eq-Comparison:T60 Operator:T36 Temporal-Unit:T41 Value:T49
T61	Eq-Comparison 161 181	≥6 consecutive weeks
E38	Eq-Comparison:T61 Operator:T37 Value:T50 Temporal-Unit:T42
T62	Eq-Comparison 344 347	≥16
E39	Eq-Comparison:T62 Operator:T38 Value:T53
T63	Eq-Comparison 376 379	≥ 8
E40	Eq-Comparison:T63 Operator:T39 Value:T56
T64	Eq-Comparison 338 342	0-42
E41	Eq-Comparison:T64 Operator:T46 Value:T51 Value2:T52
T65	Eq-Comparison 370 374	0-21
E42	Eq-Comparison:T65 Operator:T47 Value:T54 Value2:T55
T66	Eq-Comparison 939 946	history
E43	Eq-Comparison:T66 Temporal-Period:T67
T67	Eq-Temporal-Period 939 946	history
A14	Eq-Temporal-Period-Value T67 past
T76	Or 30 33	and
E2	Or:T76 Arg:T32 Arg2:T29
T45	Study 115 124	screening
E4	Study:T45 
T70	Temporal-Connection 106 114	prior to
E6	Temporal-Connection:T70 Arg:E37 Arg2:E4
A16	Temporal-Connection-Type-Value E6 before
T71	Condition 142 146	itch
E8	Condition:T71 Name:T77
T77	Condition-Name 142 146	itch
T78	And 147 150	and
E10	And:T78 Arg:E8 Arg2:E30
T72	Temporal-Connection 182 190	prior to
E12	Temporal-Connection:T72 Arg:E38 Arg2:E14
A17	Temporal-Connection-Type-Value E12 before
T73	Study 191 200	screening
E14	Study:T73 
T79	Drug 233 250	H1-antihistamines
E16	Drug:T79 Name:T80
T80	Drug-Name 233 250	H1-antihistamines
T81	Modifier 224 232	sedating
E18	Modifier:T81 Modifies:T80
T82	And 201 212	in spite of
E20	And:T82 Arg:E14 Arg2:E16
T5	Observation 320 330	UAS7 score
E5	Observation:T5 Name:T6 Eq-Comparison:E39 Eq-Comparison2:E41
T6	Observation-Name 320 330	UAS7 score
A18	Observation-Type-Value T6 clinical-score
T83	Observation 352 362	HSS7 score
E22	Observation:T83 Name:T84 Eq-Comparison:E42 Eq-Comparison2:E40
T84	Observation-Name 352 362	HSS7 score
A20	Observation-Type-Value T84 clinical-score
T85	And 348 351	and
E24	And:T85 Arg:E5 Arg2:E22
T74	Eq-Comparison 387 393	7 days
E26	Eq-Comparison:T74 Value:T57 Temporal-Unit:T43
T75	Temporal-Connection 380 386	during
E28	Temporal-Connection:T75 Arg:E22 Arg2:E26
A19	Temporal-Connection-Type-Value E28 during
T86	Study 403 416	randomization
E29	Study:T86 
T58	Temporal-Connection 394 402	prior to
E31	Temporal-Connection:T58 Arg:E26 Arg2:E29
A21	Temporal-Connection-Type-Value E31 before
T23	Procedure 462 496	Urticaria Participant Daily eDiary
E23	Procedure:T23 Name:T24
T24	Procedure-Name 462 496	Urticaria Participant Daily eDiary
T87	Procedure 498 502	UPDD
E32	Procedure:T87 Name:T88
T88	Procedure-Name 498 502	UPDD
R1	Abbrev-Of Arg1:E32 Arg2:E23	
T89	Study 528 533	study
E35	Study:T89 
T90	Temporal-Connection 504 520	for the duration
E45	Temporal-Connection:T90 Arg:E32 Arg2:E35
A22	Temporal-Connection-Type-Value E45 during
T91	Assertion 430 446	Willing and able
E46	Assertion:T91 Asserted:E23
A23	Assertion-Type-Value E46 hypothetical
T92	Study 590 595	study
E47	Study:T92 Study-Of:E48
T93	Procedure 596 606	treatments
E48	Procedure:T93 
T94	Condition 559 575	Hypersensitivity
E49	Condition:T94 Name:T95
T95	Condition-Name 559 575	Hypersensitivity
R2	Caused-By Arg1:E49 Arg2:E48	
T96	Modifier 684 691	chronic
E50	Modifier:T96 Modifies:T2
R3	Equivalent-To Arg1:E1 Arg2:E7	
T97	Modifier 628 639	predominant
E51	Modifier:T97 Modifies:T8
T98	Modifier 643 655	sole trigger
E52	Modifier:T98 Modifies:T8
T99	Or 640 642	or
E53	Or:T99 Arg:E51 Arg2:E52
T100	Condition 763 773	angioedema
E54	Condition:T100 Name:T101
T101	Condition-Name 763 773	angioedema
T102	Or 760 762	or
E55	Or:T102 Arg:E25 Arg2:E54
T103	Assertion 738 746	symptoms
E56	Assertion:T103 Asserted:E25 Asserted2:E54
A24	Assertion-Type-Value E56 possible
T104	Condition 724 732	diseases
E57	Condition:T104 Name:T105
T105	Condition-Name 724 732	diseases
R4	Caused-By Arg1:E25 Arg2:E57	
R5	Caused-By Arg1:E54 Arg2:E57	
T106	Other 718 723	Other
E58	Other:T106 Is-Other:E57
T107	Other 779 784	Other
E59	Other:T107 Is-Other:E15
T108	Condition 822 829	itching
E60	Condition:T108 Name:T109
T109	Condition-Name 822 829	itching
T110	Modifier 814 821	chronic
E61	Modifier:T110 Modifies:T109
R6	Caused-By Arg1:E60 Arg2:E15	
T111	Study 884 889	study
E62	Study:T111 Stability:T112
T112	Stability 841 850	influence
A25	Stability-Value T112 change
T113	Assertion 835 840	might
E63	Assertion:T113 Asserted:T112
A26	Assertion-Type-Value E63 hypothetical
R7	Caused-By Arg1:T112 Arg2:E60	
T114	Assertion 929 938	suspected
E64	Assertion:T114 Asserted:E44
A27	Assertion-Type-Value E64 possible
T68	Condition 983 1001	infectious disease
E44	Condition:T68 Name:T69 Temporality:E43 Temporality2:E68
T69	Condition-Name 983 1001	infectious disease
T115	Modifier 973 982	recurrent
E65	Modifier:T115 Modifies:T69
T116	Modifier 962 969	chronic
E66	Modifier:T116 Modifies:T69
T117	Or 970 972	or
E67	Or:T117 Arg:E66 Arg2:E65
T118	Eq-Comparison 953 960	ongoing
E68	Eq-Comparison:T118 Temporal-Period:T119
T119	Eq-Temporal-Period 953 960	ongoing
A15	Eq-Temporal-Period-Value T119 present
R8	Example-Of Arg1:E3 Arg2:E44	
T120	Modifier 1074 1082	atypical
E69	Modifier:T120 Modifies:T10
R9	Example-Of Arg1:E17 Arg2:E3	
R10	Example-Of Arg1:E9 Arg2:E3	
R11	Example-Of Arg1:E19 Arg2:E3	
R12	Example-Of Arg1:E11 Arg2:E3	
T121	Or 1112 1114	or
E70	Or:T121 Arg:E19 Arg2:E11
T122	Condition 1131 1134	HIV
E71	Condition:T122 Name:T123
T123	Condition-Name 1131 1134	HIV
T124	Modifier 1146 1147	B
E72	Modifier:T124 Modifies:T22
T125	Modifier 1148 1149	C
E73	Modifier:T125 Modifies:T22
T126	Or 1147 1148	/
E74	Or:T126 Arg:E72 Arg2:E73
R13	Example-Of Arg1:E71 Arg2:E44	
R14	Example-Of Arg1:E21 Arg2:E44	
T127	Condition 1156 1164	Pregnant
E75	Condition:T127 Name:T128
T128	Condition-Name 1156 1164	Pregnant
T129	Or 1165 1167	or
E76	Or:T129 Arg:E75 Arg2:E27
T130	Condition 1177 1186	lactating
E77	Condition:T130 Name:T131
T131	Condition-Name 1177 1186	lactating
R15	Equivalent-To Arg1:E77 Arg2:E27	
T132	Life-Stage-And-Gender 1188 1193	women
A28	Life-Stage-And-Gender-Type T132 female
R16	If-Then Arg1:T132 Arg2:E77	
T133	Life-Stage-And-Gender 1199 1204	Women
A29	Life-Stage-And-Gender-Type T133 female
T134	Condition 1208 1231	child-bearing potential
E78	Condition:T134 Name:T135
T135	Condition-Name 1208 1231	child-bearing potential
T136	And 1205 1207	of
E79	And:T136 Arg:T133 Arg2:E78
T137	Negation 1232 1235	not
E80	Negation:T137 Negates:E13
T138	Modifier 1242 1266	highly effective methods
E81	Modifier:T138 Modifies:T14
T139	Eq-Comparison 1236 1241	using
E82	Eq-Comparison:T139 Temporal-Period:T140
T140	Eq-Temporal-Period 1236 1241	using
A30	Eq-Temporal-Period-Value T140 present
T141	Negation 220 223	non
E83	Negation:T141 Negates:E18
